My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
SNDX nasdaq
United States
Syndax Pharmaceuticals

Syndax Pharmaceuticals Stock Analysis & Ratings

Syndax Pharmaceuticals Stock Analysis Overview

Smart Score
1
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Syndax Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

SNDX

SNDX Stock Stats

Previous Close$18.49
Open$18.75
Bid0 x 0
Ask0 x 0
Today’s Range$18.34 - $19.035
52-Week Range$13.02 - $27.85
Volume434.51K
Average Volume517.83K
Market Cap$903.99M
Beta1.50
P/E Ratio-9.9
EPS-1.88
Earnings DateNov 11, 2021

Company Description

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
Sector
Healthcare
Industry
Biotechnology
CEO
Briggs W. Morrison
Employees
43
ISIN
US87164F1057
Address
35 Gatehouse Drive, Waltham, MA, 02451, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

SNDX FAQ

What was Syndax Pharmaceuticals’s price range in the past 12 months?
Syndax Pharmaceuticals lowest stock price was $13.02 and its highest was $27.85 in the past 12 months.
    What is Syndax Pharmaceuticals’s market cap?
    Syndax Pharmaceuticals’s market cap is $903.99M.
      What is Syndax Pharmaceuticals’s price target?
      The average price target for Syndax Pharmaceuticals is $27.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $32.00 ,the lowest forecast is $21.00. The average price target represents 48.84% Increase from the current price of $18.59.
        What do analysts say about Syndax Pharmaceuticals?
        Syndax Pharmaceuticals’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Syndax Pharmaceuticals’s upcoming earnings report date?
          Syndax Pharmaceuticals’s upcoming earnings report date is Nov 11, 2021 which is in 24 days.
            How were Syndax Pharmaceuticals’s earnings last quarter?
            Syndax Pharmaceuticals released its earnings results on Aug 09, 2021. The company reported -$0.444 earnings per share for the quarter, beating the consensus estimate of -$0.715 by $0.271.
              Is Syndax Pharmaceuticals overvalued?
              According to Wall Street analysts Syndax Pharmaceuticals’s price is currently Undervalued.
                Does Syndax Pharmaceuticals pay dividends?
                Syndax Pharmaceuticals does not currently pay dividends.
                What is Syndax Pharmaceuticals’s EPS estimate?
                Syndax Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Syndax Pharmaceuticals have?
                Syndax Pharmaceuticals has 48,630,000 shares outstanding.
                  What happened to Syndax Pharmaceuticals’s price movement after its last earnings report?
                  Syndax Pharmaceuticals reported an EPS of -$0.444 in its last earnings report, beating expectations of -$0.715. Following the earnings report the stock price went up 6.988%.
                    Which hedge fund is a major shareholder of Syndax Pharmaceuticals?
                    Among the largest hedge funds holding Syndax Pharmaceuticals’s share is HealthCor Management, L.P.. It holds Syndax Pharmaceuticals’s shares valued at 30M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis